TCT-778 Valve-In-Valve (ViV) Transcatheter Aortic Valve Replacement (TAVR): A Comparison of Failed Stentless and Stented Surgical Bio-prosthetic Aortic Valve
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2017.09.664
Abstract: The literature is limited on ViV TAVR in stentless vs. stented bioprosthetic surgical aortic valve. We retrospectively analyzed 36 patients who underwent ViV TAVR in prior surgical bioprosthetic valves at Wake Forest Baptist Medical Center… read more here.
Keywords: stentless stented; valve; aortic valve; viv tavr ... See more keywords
Transcatheter Aortic Valve Replacement of Failed Surgically Implanted Bioprostheses: The STS/ACC Registry.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.04.074
Abstract: BACKGROUND Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) has been shown to be feasible, yet the safety and efficacy in relation to native valve (NV) TAVR are not known. OBJECTIVES This study sought to evaluate… read more here.
Keywords: tavr; aortic valve; valve; valve replacement ... See more keywords
Bioprosthetic valve battles: The destiny of the dysfunctional valve
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cardiac Surgery"
DOI: 10.1111/jocs.16034
Abstract: Recently, industrial technology and approaches in aortic valve replacement (AVR) have evolved in ways cardiac surgeons and cardiologists would have never imagined. In particular, transcatheter aortic valve implantation (TAVR/TAVI) has had promising results in comparison… read more here.
Keywords: fracture; tavr; aortic valve; mortality ... See more keywords
New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1004103
Abstract: Objective To assess the incidence of new adverse coronary events (NACE) following transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR). Background ViV-TAVR is an accepted treatment for degenerative prostheses among patients with high surgical-risk.… read more here.
Keywords: year; tavr; viv tavr; coronary artery ... See more keywords